Nomura Holdings’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.3M | Sell |
18,984
-23,644
| -55% | -$11.8M | 0.03% | 401 |
|
|
2025
Q4 | $20.8M | Buy |
42,628
+38,576
| +952% | +$18M | 0.03% | 312 |
|
|
2025
Q3 | $1.7M | Buy |
4,052
+745
| +23% | +$251K | ﹤0.01% | 1203 |
|
|
2025
Q2 | $950K | Sell |
3,307
-1,026
| -24% | -$307K | ﹤0.01% | 1019 |
|
|
2025
Q1 | $1.34M | Sell |
4,333
-1,591
| -27% | -$545K | ﹤0.01% | 1184 |
|
|
2024
Q4 | $2.09M | Buy |
+5,924
| New | +$2.18M | ﹤0.01% | 1108 |
|
|
2024
Q3 | – | Sell |
-792
| Closed | -$252K | – | 2007 |
|
|
2024
Q2 | $252K | Buy |
+792
| New | +$210K | ﹤0.01% | 1525 |
|
|
2021
Q2 | – | Sell |
-6,250
| Closed | -$1.05M | – | 2346 |
|
|
2021
Q1 | $1.05M | Buy |
+6,250
| New | +$1.04M | ﹤0.01% | 1077 |
|
|
2018
Q4 | – | Sell |
-1,625
| Closed | -$205K | – | 1414 |
|
|
2018
Q3 | $205K | Sell |
1,625
-3,480
| -68% | -$430K | ﹤0.01% | 1180 |
|
|
2018
Q2 | $578K | Buy |
+5,105
| New | +$561K | ﹤0.01% | 971 |
|
|
2018
Q1 | – | Sell |
-11,621
| Closed | -$1.72M | – | 1695 |
|
|
2017
Q4 | $1.72M | Buy |
11,621
+4,791
| +70% | +$609K | ﹤0.01% | 936 |
|
|
2017
Q3 | $802K | Buy |
6,830
+3,724
| +120% | +$476K | ﹤0.01% | 1113 |
|
|
2017
Q2 | $403K | Buy |
+3,106
| New | +$387K | ﹤0.01% | 1279 |
|
|
2017
Q1 | – | Sell |
-3,325
| Closed | -$472K | – | 1635 |
|
|
2016
Q4 | $472K | Buy |
+3,325
| New | +$425K | ﹤0.01% | 1258 |
|
|
2016
Q3 | – | Sell |
-2,149
| Closed | -$227K | – | 1393 |
|
|
2016
Q2 | $227K | Sell |
2,149
-2,090
| -49% | -$233K | ﹤0.01% | 1013 |
|
|
2016
Q1 | $479K | Sell |
4,239
-7
| -0.2% | -$886 | ﹤0.01% | 892 |
|
|
2015
Q4 | $666K | Sell |
4,246
-301
| -7% | -$43.8K | ﹤0.01% | 938 |
|
|
2015
Q3 | $600K | Sell |
4,547
-8,581
| -65% | -$1.38M | ﹤0.01% | 899 |
|
|
2015
Q2 | $2.28M | Buy |
+13,128
| New | +$2.36M | 0.01% | 760 |
|
|
2014
Q3 | – | Sell |
-9,339
| Closed | -$833K | – | 3064 |
|
|
2014
Q2 | $833K | Buy |
9,339
+7,194
| +335% | +$692K | ﹤0.01% | 1522 |
|
|
2014
Q1 | $202K | Sell |
2,145
-1,759
| -45% | -$180K | ﹤0.01% | 2336 |
|
|
2013
Q4 | $441K | Sell |
3,904
-11,820
| -75% | -$1.07M | ﹤0.01% | 1342 |
|
|
2013
Q3 | $1.24M | Sell |
15,724
-28,191
| -64% | -$2.06M | 0.01% | 1000 |
|
|
2013
Q2 | $2.89M | Buy |
+43,915
| New | +$2.83M | 0.02% | 505 |
|
Other funds holding UTHR
ACA
VPM
VCM
Nomura Holdings's UTHR Position: Q1 2026 in Review
Nomura Holdings reduced its United Therapeutics (UTHR) stake by 55% in Q1 2026, selling an estimated $11.8M and leaving 18,984 shares worth $11.3M. The position accounts for 0.03% of the portfolio, ranked #401.
Nomura Holdings first reported a position in UTHR in Q2 2013 and has held it in 24 quarters since. The position peaked at $20.8M in Q4 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Nomura Holdings held 18,984 shares of United Therapeutics worth $11.3M as of Q1 2026.
- Nomura Holdings sold 23,644 United Therapeutics shares in Q1 2026, an estimated $11.8M.
- United Therapeutics made up 0.03% of Nomura Holdings's portfolio in Q1 2026, its #401 holding.
- Nomura Holdings first reported a position in United Therapeutics in Q2 2013 and has held it in 24 quarters since.
- Nomura Holdings's United Therapeutics position peaked at $20.8M in Q4 2025.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.